Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Neoplasms × obinutuzumab × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 24 Lymphoma, Follicular 15 Lymphoma, Non-Hodgkin 9 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma, Mantle-Cell 5 Lymphoma 5 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia 3 Neoplasms 2 Bronchiolitis Obliterans Syndrome 2 Tumor Lysis Syndrome 1 Solid Tumors 1 Recurrence 1 Oncology Patients Receiving Chemotherapy 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Leukemia, Prolymphocytic, B-Cell 1 Leukemia, Lymphoid 1 Leukemia, Hairy Cell 1 Indolent Non-Hodgkin's Lymphoma 1 Chromosome 17 deletion 1 Carcinoma, Non-Small-Cell Lung 1 B-cell Malignancies 1 Anemia 1

Interventions

Fluorouracil 32 Cisplatin 32 Radiotherapy 29 Oxaliplatin 28 Paclitaxel 20 Irinotecan 20 Docetaxel 20 pembrolizumab 19 Leucovorin 18 Capecitabine 16 Cetuximab 11 Bevacizumab 11 Carboplatin 10 Radiation 9 Trastuzumab 8 Surgical Procedures, Operative 8 Panitumumab 6 Epirubicin 5 Neoadjuvant Therapy 4 Esophagectomy 4 Erlotinib Hydrochloride 4 tisotumab vedotin 3 durvalumab 3 Sunitinib 3 Gemcitabine 3 Chemotherapy, Adjuvant 3 Albumin-Bound Paclitaxel 3 pegfilgrastim 2 niraparib 2 epacadostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡